Nibedita Chattopadhyay

Director, Translational Sciences at TCR2 Therapeutics - Cambridge, MA, US

Nibedita Chattopadhyay's Contact Details
HQ
617-949-5200
Location
Company
TCR2 Therapeutics
Nibedita Chattopadhyay's Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Nibedita Chattopadhyay
Nibedita Chattopadhyay currently works for TCR² Therapeutics Inc..
Nibedita Chattopadhyay's role at TCR² Therapeutics Inc. is Director, Translational Sciences.
Nibedita Chattopadhyay's email address is ***@tcr2.com. To view Nibedita Chattopadhyay's full email address, please signup to ConnectPlex.
Nibedita Chattopadhyay works in the Biotechnology industry.
Nibedita Chattopadhyay's colleagues at TCR2 Therapeutics are Breckon CPA, Michael Ross, Aishwarya Srivastava, Julio Gomez-Rodriguez, Cristin Berkey, Elizabeth M.A., Juanita Rivera and others.
Nibedita Chattopadhyay's phone number is 617-949-5200
See more information about Nibedita Chattopadhyay